article thumbnail

Remote patient monitoring in Medicare needs more oversight: OIG

Healthcare Dive

Regulators say Medicare needs more data and oversight to avoid fraud and misuse. Digital health advocates argue the service is still crucial for managing chronic conditions.

Medicare 325
article thumbnail

CMS holds accountable care organizations harmless for ‘highly suspect’ Medicare billing

Healthcare Dive

Aberrant billing for urinary catheters last year could have made it harder for ACOs in Medicare to bring in shared savings. That’s no longer the case under a new final rule.

Medicare 306
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Semaglutide coverage for weight loss could cost Medicare billions: study

Healthcare Dive

If all newly eligible patients received semaglutide, Medicare Part D spending could increase by $34 billion to $145 billion each year, according to new research.

Medicare 317
article thumbnail

Humana inks minority investment in Medicare choice tool Healthpilot

Healthcare Dive

The company uses AI to recommend Medicare Advantage, Medicare supplement and prescription drug plans based on enrollees’ healthcare preferences and needs.

Medicare 308
article thumbnail

Amazon expands drug subscription program to Medicare members

Healthcare Dive

RxPass is now available to more than 50 million Medicare members after Amazon brought it into compliance with the insurance program’s regulatory standards.

Medicare 321
article thumbnail

CMS revised Medicare Advantage star ratings. Here’s which payers benefited.

Healthcare Dive

More than 60 Medicare Advantage health plans from 40 insurers have received a higher star rating for 2024, according to a Healthcare Dive analysis.

Medicare 299
article thumbnail

Medicare to cover Novo’s obesity drug for some patients

Healthcare Dive

Two weeks after the FDA updated Wegovy’s label, Medicare changed its stance to allow people with a history of heart disease to receive treatment, a shift that could further boost access to the fast-selling medicine.

Medicare 331